• Janux held its 2026 annual shareholder meeting on June 11, 2026.
• Shareholders ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• An advisory resolution on executive compensation passed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Janux Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-269387), on June 12, 2026, and is solely responsible for the information contained therein.